Enhanced Antiproliferative Activity of Docetaxel by Extremely Low Frequency Electromagnetic Fields in MCF-7 Breast Cancer Cells.
Research
RF Safe Research Library
Jan 1, 2025
This in vitro study tested whether extremely low-frequency electromagnetic fields (50 Hz, 20 mT) enhance docetaxel effects in MCF-7 breast cancer cells. The authors report that combining ELF-EMF with docetaxel produced a similar reduction in cell viability at a lower docetaxel concentration than docetaxel alone,…
The exposure to extremely low frequency electromagnetic-fields inhibits the growth and potentiates the sensitivity to chemotherapy of bidimensional and tridimensional human osteosarcoma models.
Research
RF Safe Research Library
Jan 1, 2024
This in vitro study tested a specific extremely low frequency electromagnetic field (ELF-EMF) on three human osteosarcoma cell lines grown in 2D and 3D spheroid models. The abstract reports that ELF-EMF exposure inhibited proliferation and altered mitochondrial metabolism in the cancer models. It also reports…
The effect of 900 MHz electromagnetic fields on biological pathways induced by electrochemotherapy.
Research
RF Safe Research Library
Jan 1, 2021
This study examined whether 900 MHz RF-EMF exposure modifies biological pathways associated with electrochemotherapy (ECT) in 4T1 cells and in mice bearing 4T1 tumors. At the highest reported power density (349 µW/cm), RF exposure was reported to increase ECT-induced tumor hypoxia and increase IFN-γ compared with ECT…
Chemotherapy side-effect management using mobile phones.
Research
RF Safe Research Library
Jan 1, 2008
This conference paper describes a mobile-phone telemedicine system for managing chemotherapy side-effects at home using symptom diaries and automated alerts to nurses. Six patients used the system for two cycles of oral chemotherapy. The abstract reports two instances where moderate symptoms deteriorated to more…